MADRIGAL PHARMACEUTICALS, INC. (MDGL) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $6.6M. Most recent filing: Sept. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 11, 2026 filed Sept. 9, 2026 | Sibold William John President and CEO | −$6,239,198 | 11,583 | −6% | Yes | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 17, 2026 | Kelley Shannon T General Counsel | −$341,940 | 664 | −5% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 15, 2026 | REED JOHN C Director | $0 | 1,725 | +150% | No | |
|
|
||||||
| July 20, 2026 filed July 17, 2026 | Sibold William John President and CEO | — | +47,500 | +29% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free